{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:03:03Z","timestamp":1769598183450,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.lpm.2018.01.020","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T09:37:41Z","timestamp":1520501861000},"page":"251-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sp\u00e9cificit\u00e9s de la prise en charge de la femme \u00e9pileptique"],"prefix":"10.1016","volume":"47","author":[{"given":"Sophie","family":"Dupont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2018.01.020_bib0230","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1528-1157.1997.tb01197.x","article-title":"Three patterns of catamenial epilepsy","volume":"38","author":"Herzog","year":"1997","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.lpm.2018.01.020_bib0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.seizure.2007.11.014","article-title":"Catamenial epilepsy: definition, prevalence, pathophysiology and treatment","volume":"17","author":"Herzog","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.lpm.2018.01.020_bib0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.seizure.2015.02.024","article-title":"Catamenial epilepsy: update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial","volume":"28","author":"Herzog","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.lpm.2018.01.020_bib0245","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0b013e318259e1f9","article-title":"The Progesterone Trial Study Group Progesterone versus placebo therapy for women with epilepsy: a randomized clinical trial","volume":"78","author":"Herzog","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2018.01.020_bib0250","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.yebeh.2009.01.024","article-title":"Antiepileptic drugs: are women aware of interactions with oral contraceptives and potential teratogenicity?","volume":"14","author":"Pack","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.lpm.2018.01.020_bib0255","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.321.7262.674","article-title":"Population based, prospective study of the care of women with epilepsy in pregnancy","volume":"321","author":"Fairgrieve","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2018.01.020_bib0260","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). U.S. medical eligibility criteria for contraceptive use, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.lpm.2018.01.020_bib0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.lpm.2018.01.020_bib0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/ecp.10.3","article-title":"Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives","volume":"3","author":"Reddy","year":"2010","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.lpm.2018.01.020_bib0275","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2018.01.020_bib0280","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2006.00629.x","article-title":"Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy","volume":"47","author":"Galimberti","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.lpm.2018.01.020_bib0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2016.04.020","article-title":"Differential impact of contraceptive methods on seizures varies by antiepileptic drug category: findings of the epilepsy Birth Control Registry","volume":"60","author":"Herzog","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.lpm.2018.01.020_bib0290","first-page":"285","article-title":"Appendix C: AAN summary of evidence-based guideline for clinicians: management issues for women with epilepsy--focus on pregnancy: vitamin K, folic acid, blood levels, and breastfeeding","volume":"22","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"21","key":"10.1016\/j.lpm.2018.01.020_bib0295","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Pregnancy Registry comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hern\u00e1ndez-D\u00edaz","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lpm.2018.01.020_bib0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2018.01.020_bib0305","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2018.01.020_bib0310","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Holmes","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2018.01.020_bib0315","first-page":"11","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child (Review)","author":"Weston","year":"2016","journal-title":"Cochrane Datab Syst Rev"},{"issue":"1","key":"10.1016\/j.lpm.2018.01.020_bib0320","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Med"},{"issue":"405","key":"10.1016\/j.lpm.2018.01.020_bib0325","first-page":"e1","article-title":"National Birth Defects Prevention Study. Use of topiramate in pregnancy and risk of oral clefts","volume":"207","author":"Margulis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"18","key":"10.1016\/j.lpm.2018.01.020_bib0330","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0000000000002540","article-title":"Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies","volume":"86","author":"Dolk","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.lpm.2018.01.020_bib0335","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1185\/030079905X43640","article-title":"Safety of the newer antiepileptic drug oxcarbazepine during pregnancy","volume":"21","author":"Montouris","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"24","key":"10.1016\/j.lpm.2018.01.020_bib0340","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1212\/WNL.0000000000002767","article-title":"Pregnancy outcome following maternal exposure to pregabalin may call for concern","volume":"86","author":"Winterfeld","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.lpm.2018.01.020_bib0345","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/epi.13415","article-title":"Antiepileptic drug combinations not involving valproate and the risk of fetal malformations","volume":"57","author":"Vajda","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.lpm.2018.01.020_bib0350","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2018.01.020_bib0355","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3\u00a0years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2018.01.020_bib0360","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2018.01.020_bib0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","article-title":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","volume":"54","author":"Deshmukh","year":"2016","journal-title":"Neurotoxicol Teratol"},{"issue":"9","key":"10.1016\/j.lpm.2018.01.020_bib0370","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1157.1999.tb00852.x","article-title":"Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents","volume":"40","author":"Koch","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.lpm.2018.01.020_bib0375","first-page":"CD010236","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"10","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"10.1016\/j.lpm.2018.01.020_bib0380","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1212\/WNL.0000000000003157","article-title":"Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate","volume":"87","author":"Bromley","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2018.01.020_bib0385","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2018.01.020_bib0390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000195888.51845.80","article-title":"Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry","volume":"66","author":"Group ES","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lpm.2018.01.020_bib0395","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00415-012-6662-8","article-title":"Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy--a matter of importance for the baby?","volume":"260","author":"Rauchenzauner","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2018.01.020_bib0400","first-page":"404","article-title":"Effect of epilepsy in pregnancy on fetal growth restriction: a systematic review and meta-analysis","author":"Chen","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"10.1016\/j.lpm.2018.01.020_bib0405","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1471-0528.2010.02694.x","article-title":"Delivery outcome of women with epilepsy: a population-based cohort study","volume":"117","author":"Borthen","year":"2010","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.lpm.2018.01.020_bib0410","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","article-title":"Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study Group Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6\u00a0years","volume":"168","author":"Meador","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.lpm.2018.01.020_bib0415","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1046\/j.1528-1157.2001.13701r.x","article-title":"Premature ovarian failure in women with epilepsy","volume":"42","author":"Klein","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.lpm.2018.01.020_bib0420","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1528-1157.1999.tb02076.x","article-title":"Effects of menopause on seizures in women with epilepsy","volume":"40","author":"Abbasi","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.lpm.2018.01.020_bib0425","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1528-1157.1999.tb02012.x","article-title":"The effect of menopause and perimenopause on the course of epilepsy","volume":"40","author":"Harden","year":"1999","journal-title":"Epilepsia"},{"issue":"353\u2013355","key":"10.1016\/j.lpm.2018.01.020_bib0430","first-page":"23","article-title":"Characterization and health risk assessment of postmenopausal women with epilepsy","volume":"1","author":"McAuley","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.lpm.2018.01.020_bib0435","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/01.wnl.0000180910.72487.18","article-title":"Effect of antiepileptic medication on bone mineral measures","volume":"65","author":"Petty","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lpm.2018.01.020_bib0440","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0404.2011.01509.x","article-title":"Epilepsy: fractures and the role of cumulative antiepileptic drug load","volume":"125","author":"Beerhorst","year":"2012","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.lpm.2018.01.020_bib0445","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.maturitas.2010.03.026","article-title":"EMAS position statement: managing the menopause in women with epilepsy","volume":"66","author":"Erel","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.lpm.2018.01.020_bib0450","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1528-1167.2006.00507.x","article-title":"Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study","volume":"47","author":"Harden","year":"2006","journal-title":"Epilepsia"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218300630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218300630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T08:28:04Z","timestamp":1535012884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498218300630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0755498218300630"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.01.020","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sp\u00e9cificit\u00e9s de la prise en charge de la femme \u00e9pileptique","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}